| Literature DB >> 29491017 |
Alex-Mikael Barkoff1, Jussi Mertsola2, Denis Pierard3, Tine Dalby4, Silje Vermedal Hoegh5, Sophie Guillot6, Paola Stefanelli7, Marjolein van Gent8, Guy Berbers8, Didrik F Vestrheim9, Margrethe Greve-Isdahl9, Lena Wehlin10, Margaretha Ljungman10, Norman K Fry11, Kevin Markey12, Kari Auranen13,14, Qiushui He15,16.
Abstract
One reason for increased pertussis incidence is the adaptation of Bordetella pertussis to vaccine-induced immunity by modulating its genomic structure. This study, EUpert IV, includes 265 isolates collected from nine European countries during 2012 to 2015 (n = 265) and compares the results to previous EUpert I to III studies (1998 to 2009). The analyses included genotyping, serotyping, pulsed-field gel electrophoresis (PFGE), and multilocus variable-number tandem-repeat analysis (MLVA). Genotyping results showed only small variations among the common virulence genes of B. pertussis The frequencies of serotypes Fim2 and Fim3 varied among the four collections. Genomic analyses showed that MLVA type 27 increased to 80% between the periods of 1998 to 2001 and 2012 to 2015. Two PFGE profiles, BpSR3 (29.4%) and BpSR10 (27.2%), constituted more than 50% of the circulating isolates in the present collection. Our study indicates that the European B. pertussis population is changing and became more homogenous after the introduction of acellular pertussis vaccines.Entities:
Keywords: Bordetella pertussis; Europe; MLVA; PFGE; genotyping; serotyping
Mesh:
Substances:
Year: 2018 PMID: 29491017 PMCID: PMC5925733 DOI: 10.1128/JCM.01998-17
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948